S.Sivaraj, “Bedaquiline-a potential inhibitor of COVID-19 main protease based on molecular docking”, Int. J. of Res. in Pharmacology &Pharmacotherapeutics , vol. 9, no. 2, pp. 136-144, Mar. 2021.